SSX2 and synovial sarcoma: The pathognomonic abnormality for SS is the genetic translocation t(X;18((p11.2q11.2)), resulting in the fusion specific transcripts SS18-SSX1, SS18-SSX2 and rarely the SS18-SSX4, in >95% of cases [52,53].